IP Library Granted Patent US 9,856,456
Granted Patent B2
US 9,856,456 · App. 14/863,539 · Granted Jan 2, 2018

Delivery agent

Inventors: Arunas Lagunavicius (Vilnius, LT); Lolita Zaliauskiene (Vilnius, LT)
Assignee: THERMO FISHER SCIENTIFIC BALTICS UAB
C12N5/0693C08G73/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,856,456
App. No.
14/863,539
Granted
Jan 2, 2018
Kind
B2
Abstract

A composition comprising a polycationic agent and a polyanionic agent, and kits comprising the composition, is provided. In embodiments, the polyanionic agent is a nucleic acid and the polycationic agent is a modified polyalkyleneimine polymer.

Claims (41)

1. A composition for delivering a peptide or protein into a cell, which composition comprises a polycationic agent and a polyanionic agent, wherein the polyanionic agent is a nucleic acid and the polycationic agent is a modified polyalkyleneimine polymer having a repeat unit of formula I or formula V:

where:

Z1 and Z2 each independently represent —H, alkyl or a branching chain;

Y1 and Y2 each independently represent a group having formula II or III:

where:

X1 is selected from the group consisting of —H, -alkyl, —SH, —CN, —NH 2 , —N(alkyl) 2 ,—NH(alkyl), —CONH 2 -,

—NHCONH 2 ,

X2 is selected from the group consisting of —CH 2 —, —O—, —S—, —NH—, or —N(alkyl)-;

provided that at least one of X1 and X2 is a hydrophilic group;

m1, m2, n1 and n2 each independently is 0, 1, 2or 3; and

p1 and p2 each independently is 1 or 2.

2. The composition of claim 1 , wherein the nucleic acid is DNA.

3. A kit for delivering a peptide or protein into a cell, which kit comprises a polycationic agent in a first container and a polyanionic agent in a second container, wherein the polyanionic agent is a nucleic acid and the polycationic agent is a modified polyalkyleneimine polymer having a repeat unit of formula I or formula V:

where:

Z1and Z2 each independently represent —H, alkyl or a branching chain;

Y1 and Y2 each independently represent a group having formula II or III:

where:

X1 is selected from the group consisting of —H, -alkyl, —SH, —CN, —NH 2 , —N(alkyl) 2 ,—NH(alkyl), —CONH 2 -,

CONH 2 , —NHCONH 2 ,

X2is selected from the group consisting of —CH 2 —, —O—, —S—, —NH—, or —N(alkyl)-;

provided that at least one of X1 and X2 is a hydrophilic group;

m1, m2, n1 and n2 each independently is 0, 1, 2or 3; and

p1 and p2 each independently is 1or 2.

4. The kit of claim 3 where the nucleic acid is DNA.

5. A method for delivering a peptide or protein into a target cell, which method comprises contacting the peptide or protein with a polycationic agent and a polyanionic agent to form a complex and contacting the complex with the target cell so as to deliver the peptide or protein thereto, wherein:

(1) the polyanionic agent is a nucleic acid; and

(2) the polycationic agent is a modified polyalkyleneimine polymer having a repeat unit of formula I or formula V:

where:

Z1 and Z2 each independently represent —H, alkyl or a branching chain;

Y1 and Y2 each independently represent a group having formula II or III:

where:

X1 is selected from the group consisting of —H, -alkyl, —SH, —CN, —NH 2 , —N(alkyl) 2 , —NH(alkyl), —CONH 2 ,

—NHCONH 2 ,

X2is selected from the group consisting of —CH 2 —, —O—, —S—, —NH—, or —N(alkyl)-;

provided that at least one of X1 and X2 is a hydrophilic group;

m1, m2, n1and n2 each independently is 0, 1, 2 or 3; and

p1 and p2 each independently is 1or 2.

6. The method according to claim 5 , wherein the peptide or protein is contacted with the polyanionic agent prior to contacting the polycationic agent.

7. The method according to claim 5 , wherein the peptide or protein comprises an enzyme, an antibody or an inert protein.

8. The method according to claim 5 , wherein the target cell is a suspension cell, an adherent cell, a primary cell or cultured cell.

9. The method of claim 5 where the nucleic acid is DNA.

Assignments (2)
CHANGE OF NAME Recorded Sep 16, 2016
From: FERMENTAS UAB
To: THERMO FISHER SCIENTIFIC BALTICS UAB
Reel/Frame 040059/0678 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: LAGUNAVICIUS, ARUNAS; ZALIAUSKIENE, LOLITA
To: FERMENTAS UAB
Reel/Frame 039762/0774 →
Priority Claims (1)
GB 0917792.4 · Oct 12, 2009 · national
Continuity (4)
Continuation In Part 14147028 · Jan 3, 2014
Division 12901840 · Oct 11, 2010
Related Publication 20160024475A1 · Jan 28, 2016
Related Publication 20170152487A9 · Jun 1, 2017